Alterations in microbiota of patients with covid-19: potential mechanisms and therapeutic interventions

HIGHLIGHTS

• who: Bin Wang from the several specific beneficial microbiota (probiotics) are promising , treatment approaches that modulate the gut microbiota [186, ]Treatment with probiotics and/or prebiotics is relatively safer and easier to prepare and administer than FMT. The National Health Commission of China has recommended the clinical administration of probiotics to patients with severe , for the purposes of restoring and maintaining gut microflora balance and preventing secondary infection. Indeed, numerous clinical trials are validating the efficacy of probiotics and/or prebiotics at reducing , duration and symptoms (Table, ). One clinical trial (ClinicalTrials.gov Identifier No. NCT05043376) is investigating . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.